Cargando…

Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications

A hyperinflammatory response during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection crucially worsens clinical evolution of coronavirus disease 2019 (COVID-19). The interaction between SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2) triggers the activation of the NACHT,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Potere, Nicola, Del Buono, Marco Giuseppe, Caricchio, Roberto, Cremer, Paul C., Vecchié, Alessandra, Porreca, Ettore, Dalla Gasperina, Daniela, Dentali, Francesco, Abbate, Antonio, Bonaventura, Aldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536001/ https://www.ncbi.nlm.nih.gov/pubmed/36209522 http://dx.doi.org/10.1016/j.ebiom.2022.104299

Ejemplares similares

Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease
por: Vecchié, Alessandra, et al.
Publicado: (2021)

Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
por: Bonaventura, Aldo, et al.
Publicado: (2022)

The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches
por: Mauro, Adolfo G., et al.
Publicado: (2021)

Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism
por: Potere, Nicola, et al.
Publicado: (2023)

High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study
por: Vecchié, Alessandra, et al.
Publicado: (2021)

Neutrophil Extracellular Traps and Cardiovascular Diseases: An Update
por: Bonaventura, Aldo, et al.
Publicado: (2020)

Lung Function and Symptoms in Post–COVID-19 Patients: A Single-Center Experience
por: Mumoli, Nicola, et al.
Publicado: (2021)

NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
por: Chiarini, Anna, et al.
Publicado: (2023)

Blood Hyperviscosity: A Novel Link Between Hyperinflammation and Hypercoagulability in COVID-19
por: Bonaventura, Aldo, et al.
Publicado: (2022)

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
por: Bonaventura, Aldo, et al.
Publicado: (2021)

NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
por: Mezzaroma, Eleonora, et al.
Publicado: (2021)

Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing
por: Potere, Nicola, et al.
Publicado: (2019)

Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis
por: Potere, Nicola, et al.
Publicado: (2020)

Developing LRP1 Agonists into a Therapeutic Strategy in Acute Myocardial Infarction
por: Potere, Nicola, et al.
Publicado: (2019)

Preservation of Contractile Reserve and Diastolic Function by Inhibiting the NLRP3 Inflammasome with OLT1177(®) (Dapansutrile) in a Mouse Model of Severe Ischemic Cardiomyopathy Due to Non-Reperfused Anterior Wall Myocardial Infarction
por: Aliaga, Joseph, et al.
Publicado: (2021)

Pericarditis and Sacroiliitis in a World Traveler
por: Vecchié, Alessandra, et al.
Publicado: (2021)

The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma
por: Correa, Victor S. M. C., et al.
Publicado: (2023)

Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19
por: Focosi, Daniele, et al.
Publicado: (2021)

Incidence Rates and Case-Fatality Rates of Cerebral Vein Thrombosis: A Population-Based Study
por: Rezoagli, Emanuele, et al.
Publicado: (2021)

Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
por: Bonaventura, Aldo, et al.
Publicado: (2020)

Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation
por: Gregersen, Ida, et al.
Publicado: (2017)

NLRP3 inflammasome triggers interleukin‐37 release from human monocytes
por: Gritsenko, Anna, et al.
Publicado: (2022)

The Role of Interleukin-17A and NLRP3 Inflammasome in the Pathogenesis of Graves’ Ophthalmopathy
por: Lin, Chih-Chung, et al.
Publicado: (2023)

Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19
por: Di Nisio, Marcello, et al.
Publicado: (2021)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone
por: Potere, Nicola, et al.
Publicado: (2021)

NLRP3 Inflammasome Activation by Paracoccidioides brasiliensis
por: Tavares, Aldo Henrique, et al.
Publicado: (2013)

Correlation of SpO(2)/FiO(2) and PaO(2)/FiO(2) in patients with symptomatic COVID-19: An observational, retrospective study
por: Bonaventura, Aldo, et al.
Publicado: (2022)

Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19
por: Bosch, Floris T.M., et al.
Publicado: (2021)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation
por: Potere, Nicola, et al.
Publicado: (2020)

Cardiology on the cutting edge: updates from the European Society of Cardiology (ESC) Congress 2020
por: Gallego-Colon, Enrique, et al.
Publicado: (2020)

NLRP3 inflammasome is responsible for Hantavirus inducing interleukin-1β in THP-1 cells
por: Ye, Wei, et al.
Publicado: (2019)

SFTSV Infection Induced Interleukin-1β Secretion Through NLRP3 Inflammasome Activation
por: Liu, Jian-Wei, et al.
Publicado: (2021)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

Vimentin regulates activation of the NLRP3 inflammasome
por: dos Santos, Gimena, et al.
Publicado: (2015)

Polyene Macrolide Antifungal Drugs Trigger Interleukin-1β Secretion by Activating the NLRP3 Inflammasome
por: Darisipudi, Murthy Narayana, et al.
Publicado: (2011)

Acute Glycemic Control in Prediabetes Individuals Favorably Alters Serum NLRP3 Inflammasome and Related Interleukins
por: Alfadul, Hend, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n44pdccfoso6vjrja1nvuibat1